Evidence map›Paper›PMID 34663477›Full record

ArticleOne health outlook2021

Antimicrobial resistance national level dialogue and action in Ghana: setting and sustaining the agenda and outcomes.

Augustina Koduah, Martha Gyansa-Lutterodt, George Kwesi Hedidor, Reginald Sekyi-Brown, Michelle Asiedu-Danso, Brian Adu Asare, Angela Ama Ackon, Edith Andrews Annan

Open access · goldAbstract read
In one paragraph

Article in One health outlook, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Augustina KoduahDepartment of Pharmacy Practice and Clinical Pharmacy, School of Pharmacy University of Ghana, P. O. Box LG43, Legon, Ghana. akoduah@ug.edu.gh.ORCID http://orcid.org/0000-0001-9915-5333
Martha Gyansa-LutterodtTechnical Coordination Directorate, Ministry of Health, P. O. Box M44, Accra, Ghana.
George Kwesi HedidorWorld Health Organization Country Office for Ghana, P.O Box MB 142, Accra, Ghana.
Reginald Sekyi-BrownDepartment of Pharmacy Practice and Clinical Pharmacy, School of Pharmacy University of Ghana, P. O. Box LG43, Legon, Ghana.
Michelle Asiedu-DansoDepartment of Pharmacy Practice and Clinical Pharmacy, School of Pharmacy University of Ghana, P. O. Box LG43, Legon, Ghana.
Brian Adu AsarePharmacy Directorate, Ministry of Health, P. O. Box M44, Accra, Ghana.
Angela Ama AckonWorld Health Organization Country Office for Ghana, P.O Box MB 142, Accra, Ghana.
Edith Andrews AnnanWorld Health Organization African Region, P.O. Box CY 348, Causeway, Harare, Zimbabwe.
University of Ghana · GHGhana Health Service · GHMinistry of Health · GHWorld Health Organization - Zimbabwe · ZW

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) has gained national and international attention. The design and launch of national policy on antimicrobial use and resistance and action plan marked a milestone in Ghana's commitment to control AMR. These strategies are some outcomes of getting and sustaining AMR issues prominence on government's agenda. Understanding the agenda setting processes, policy actors involved and policy change is important as this provides insights on how and why policy actors defined and framed AMR issues to sustain its prominence despite the changing priorities of government agenda.

objectiveTo examine the processes of setting and sustaining AMR issues on government agenda, the policy actors involved and resulting outcomes.

methodsA qualitative study was conducted and data collected through interviewing twenty-four respondents and reviewing technical working group meeting reports and health sector documents. Data was analysed drawing on Kingdon's agenda setting framework.

resultMembers of a multisectoral technical working group (AMR platform) formed in 2011 constantly built consensus on AMR problem definition, solutions and actively engaged decision makers to mobilise support and interest. The AMR platform members sustained AMR attention and prominence on government's agenda through the following multisectoral coordination mechanisms: (1) institutionalising AMR platform activities (2) gathering evidence, sharing findings, and supporting research (3) creating awareness and training (4) gaining and maintaining political support. The activities of the AMR platform contributed to three remarkable outcomes and these are (1) maintained network of AMR Champions, (2) design of a national policy on antimicrobial use and resistance in Ghana (1st edition) and national action plan (2017-2021), and (3) Ghana's hosting of the second Global call to action on AMR.

conclusionThe AMR platform members as influencers concentrated their efforts to move and sustain AMR issues on government agenda. The identified multisectoral coordination mechanisms collectively contributed to agenda setting processes and policy change. The AMR platform engagements are ongoing and it is important the momentum is maintained. As multisectoral coordination and activities are vital especially for AMR 'One Health' approach, we hope this paper presents lessons for better understanding of how and why multisectoral groups influence national level agenda setting processes.

Indexed as

Agenda settingAntimicrobial resistanceGhanaMultisectoral coordinationOne health approach

Identifiers

PMID34663477
PMCPMC8524845
OpenAlexW3207907251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.